Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial

1. Plesner, T.
2. Dimopoulos, M.A.
3. Oriol, A.
4. San-Miguel, J.
5. Bahlis, N.J.
6. Rabin, N.
7. Suzuki, K.
8. Yoon, S.-S.
9. Ben-Yehuda, D.
10. Cook, G.
11. Goldschmidt, H.
12. Grosicki, S.
13. Qin, X.
14. Fastenau, J.
15. Garvin, W.
16. Carson, R.
17. Renaud, T.
18. Gries, K.S.